Related Experiment Videos
Preimplantation genetic diagnosis: current status and new developments
1Centre for Medical Genetics, University Hospital and Medical School of the Dutch-speaking Brussels Free University, Belgium.
Human Reproduction (Oxford, England)
|August 1, 1997
Summary
Preimplantation genetic diagnosis (PGD) uses polymerase chain reaction (PCR) and fluorescent in-situ hybridization (FISH) to screen embryos for genetic diseases. This review discusses challenges and advancements in PGD technologies for early prenatal diagnosis.
Area of Science:
- Reproductive Medicine
- Genetics
- Embryology
Background:
- Preimplantation genetic diagnosis (PGD) is a crucial tool for preventing the transmission of serious genetic disorders.
- Current PGD relies on polymerase chain reaction (PCR) for monogenic diseases and fluorescent in-situ hybridization (FISH) for chromosomal abnormalities.
Purpose of the Study:
- To review the challenges and advancements in PGD technologies.
- To discuss solutions for issues like allelic drop-out in PCR and explore new developments such as cell recycling.
Main Methods:
- Review of existing literature on PGD techniques, including PCR and FISH.
- Analysis of methods to overcome technical limitations, such as fluorescent PCR and sperm separation via flow cytometry.
- Examination of combined approaches like cell recycling integrating PCR and FISH.
Main Results:
- Identified allelic drop-out as a key challenge in PCR-based PGD and highlighted fluorescent PCR as a solution.
- Evaluated sperm separation by flow cytometry for avoiding X-linked diseases.
- Discussed the application of FISH for aneuploidy detection and advancements in combined PCR-FISH techniques.
Conclusions:
- PGD technologies, while facing challenges, are continuously improving.
- New developments enhance the accuracy and scope of PGD for various genetic conditions.
- PGD offers a vital option for genetic disease prevention in assisted reproduction.